Le Lézard
Classified in: Health
Subject: Conference Calls/ Webcasts

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update


VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its third quarter 2023 financial and operating results after the close of U.S. financial markets on Wednesday, November 8, 2023.

Conference Call/Webcast Information:

Date:Wednesday, November 8, 2023
  
Time:4:30 pm Eastern Time (1:30 pm Pacific Time)
  
Dial-In:(800) 715-9871 or (646) 307-1963 for international callers
  
Conference ID:4249948
  

A live audio webcast will be available on the "Investors" section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected] 



These press releases may also interest you

at 08:34
Introducing AvryLabs.com: The Premier Online Destination for Cutting-Edge Bodybuilding Supplements
Avry Labs, LLC is thrilled to announce the redesign and launch of their e-commerce website for bodybuilding enthusiasts who seek top-quality supplements to elevate their workout routines and maximize muscle gains. Dedicated to providing...

at 08:34
Seven Cells Revolutionizes Weight Loss Journey Just in Time for Mother's Day
Seven Cells, a leading telehealth company specializing in innovative healthcare solutions, is proud to announce a groundbreaking opportunity for individuals seeking transformative weight loss solutions, just in time for Mother's Day. With a focus on...

at 08:34
Eric Monday Foundation Hosts Fundraiser to Facilitate Coach Training for Student Athlete Mental Health
On May 4, 2024, the Eric Monday Foundation (EMF) commemorated the 150th Run for the Roses at the Kentucky Derby by bringing together a diverse crowd of supporters, all rallying behind young adults and adolescents navigating mental health obstacles....

at 08:31
C3 Summit Launches C3 DAVOS OF HEALTHCAREtm in Bahrain
On April 21 & 22, 2023, Leaders in Medicine, Government, Business and Technology Attended C3 International Healthcare Summit inaugural launch of C3 DAVOS OF HEALTHCAREtm in Manama, Bahrain Continuing over a decade of international healthcare forums,...

at 08:30
Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two upcoming investor...

at 08:16
Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm
On March 28, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO: ORX) successfully issued senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "Bonds"). Pursuant to the terms and...

More news about Health...


News published on and distributed by: